rs2592595

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001374353.1(GLI2):​c.801G>A​(p.Ser267Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.959 in 1,613,450 control chromosomes in the GnomAD database, including 751,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S267S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.84 ( 57441 hom., cov: 33)
Exomes 𝑓: 0.97 ( 693937 hom. )

Consequence

GLI2
NM_001374353.1 synonymous

Scores

13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -5.92

Publications

24 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.7370595E-7).
BP6
Variant 2-120968871-G-A is Benign according to our data. Variant chr2-120968871-G-A is described in ClinVar as Benign. ClinVar VariationId is 259736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.92 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.801G>A p.Ser267Ser synonymous_variant Exon 6 of 14 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.801G>A p.Ser267Ser synonymous_variant Exon 6 of 14 1 NM_001374353.1 ENSP00000354586.5 A0A7I2PJA1

Frequencies

GnomAD3 genomes
AF:
0.840
AC:
127750
AN:
152102
Hom.:
57432
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.476
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.924
Gnomad ASJ
AF:
0.966
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.980
Gnomad FIN
AF:
0.996
Gnomad MID
AF:
0.930
Gnomad NFE
AF:
0.985
Gnomad OTH
AF:
0.889
GnomAD2 exomes
AF:
0.949
AC:
238228
AN:
251088
AF XY:
0.959
show subpopulations
Gnomad AFR exome
AF:
0.465
Gnomad AMR exome
AF:
0.963
Gnomad ASJ exome
AF:
0.968
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.995
Gnomad NFE exome
AF:
0.986
Gnomad OTH exome
AF:
0.962
GnomAD4 exome
AF:
0.971
AC:
1418808
AN:
1461228
Hom.:
693937
Cov.:
55
AF XY:
0.973
AC XY:
707184
AN XY:
726942
show subpopulations
African (AFR)
AF:
0.445
AC:
14898
AN:
33476
American (AMR)
AF:
0.959
AC:
42894
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.968
AC:
25298
AN:
26128
East Asian (EAS)
AF:
1.00
AC:
39693
AN:
39698
South Asian (SAS)
AF:
0.978
AC:
84393
AN:
86254
European-Finnish (FIN)
AF:
0.995
AC:
52695
AN:
52974
Middle Eastern (MID)
AF:
0.939
AC:
5416
AN:
5768
European-Non Finnish (NFE)
AF:
0.986
AC:
1096218
AN:
1111824
Other (OTH)
AF:
0.949
AC:
57303
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1916
3832
5749
7665
9581
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21576
43152
64728
86304
107880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.840
AC:
127800
AN:
152222
Hom.:
57441
Cov.:
33
AF XY:
0.845
AC XY:
62874
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.476
AC:
19754
AN:
41482
American (AMR)
AF:
0.924
AC:
14137
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.966
AC:
3353
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5151
AN:
5156
South Asian (SAS)
AF:
0.981
AC:
4728
AN:
4822
European-Finnish (FIN)
AF:
0.996
AC:
10579
AN:
10626
Middle Eastern (MID)
AF:
0.925
AC:
272
AN:
294
European-Non Finnish (NFE)
AF:
0.985
AC:
67035
AN:
68040
Other (OTH)
AF:
0.890
AC:
1882
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
661
1322
1984
2645
3306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.876
Hom.:
51528
Bravo
AF:
0.816
TwinsUK
AF:
0.988
AC:
3665
ALSPAC
AF:
0.987
AC:
3802
ESP6500AA
AF:
0.468
AC:
2064
ESP6500EA
AF:
0.984
AC:
8461
ExAC
AF:
0.940
AC:
114060
Asia WGS
AF:
0.959
AC:
3334
AN:
3478
EpiCase
AF:
0.985
EpiControl
AF:
0.985

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
0.014
DANN
Benign
0.86
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
7.7e-7
T
MetaSVM
Benign
-0.99
T
PhyloP100
-5.9
PROVEAN
Benign
0.91
N
REVEL
Benign
0.026
Sift
Benign
0.99
T
ClinPred
0.016
T
GERP RS
-9.8
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2592595; hg19: chr2-121726447; COSMIC: COSV108118174; API